Qi-jing Wang

机构：Sun Yat-sen University, Sun Yat-sen University Cancer Center · ORCID：0009-0000-1682-0378

发表论文 55 篇 · 总被引 118 次 · h-index 4

代表论文

• EBV promotes TCR-T-cell therapy resistance by inducing CD163+M2 macrophage polarization and MMP9 secretion (2024 · Journal for ImmunoTherapy of Cancer · 被引 40)
• The CXCL10‐CXCR3 Axis Induces Tumor‐Associated Neutrophils to Interfere with CTLs‐Mediated Antitumor Activity in EBV‐Associated Epithelial Cancers (2025 · Advanced Science · 被引 6)
• Data from SMG5 Inhibition Restrains Hepatocellular Carcinoma Growth and Enhances Sorafenib Sensitivity (2024 · 被引 1)
• Supplementary Table 1 from SMG5 Inhibition Restrains Hepatocellular Carcinoma Growth and Enhances Sorafenib Sensitivity (2024)
• Supplementary Figure 1 from SMG5 Inhibition Restrains Hepatocellular Carcinoma Growth and Enhances Sorafenib Sensitivity (2024)
• Supplementary Figure 1 from SMG5 Inhibition Restrains Hepatocellular Carcinoma Growth and Enhances Sorafenib Sensitivity (2024)